Press Releases
Personalized medicine: The partnership imperative
Cecilia Schott, business development director for personalized healthcare with AstraZeneca, on why partnerships between pharmaceutical and diagnostics companies are key to the success of personalized medicine. AstraZeneca realizes it cannot achieve its mission "to make the...
Press Releases
Gilead Sciences Refiles New Drug Application with the FDA for Single-Tablet Regimen of Truvada(R) and TMC278
Gilead Sciences, Inc. announced that it has refiled a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for the single-tablet regimen of Truvada(R) (emtricitabine and tenofovir disoproxil fumarate) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase...
Press Releases
Elan and Boehringer Ingelheim Announce Development and Manufacturing Agreement for Elan’s Antibody-Based Therapeutics Pipeline
Elan plc and Boehringer Ingelheim announced that they have entered into a global technical development and manufacturing agreement for antibody-based therapeutics. Under the terms of the agreement, Boehringer Ingelheim will perform the technical development, clinical manufacturing and all related...
Press Releases
Cancer Can Be Prevented-Latest cancer preventability data released to mark World Cancer Day
On World Cancer Day, new independent evidence confirms that the increasing global trend of unhealthy and sedentary lifestyles is responsible for putting millions at an unnecessarily high risk of cancer. New estimates released today by the World Cancer Research...
Press Releases
Nycomed to acquire Colombian company Farmacol
Nycomed announced that it is expanding its presence in Latin America through the acquisition of Laboratorios Farmacol S.A., a Colombia based pharmaceutical company, which has a strong presence in the areas of gastroenterology, respiratory and gynaecology. ...
Press Releases
Lilly and the Juvenile Diabetes Research Foundation Partner to Fund Regenerative Medicine Research in Type 1 Diabetes
Eli Lilly and Company and the Juvenile Diabetes Research Foundation (JDRF) announced that they have signed an agreement to fund early-stage research that could enable patients with type 1 diabetes to regenerate insulin-producing cells destroyed by the disease. ...
Press Releases
HCPC Alliance at Pharma Packaging & Labelling Compliance Conference
The pharmaceutical and consumers landscape is constantly evolving and the packaging requirements of the various regulatory authorities, notified bodies and healthcare professionals, have more and more market-specific local interpretations. All these will affect pharmaceutical pack design structurally in terms...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.